NXEN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. Its flagship research and development programs are focused on advancing formulations to significantly improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders. The company was founded by Richard Greenberg on November 10, 1952 and is headquartered in Glendale, CO.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
NXEN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company